Omeros paid its 3 named executives $5.8M in total in FY2025 (Dec). CEO Gregory A. Demopulos, M.D. was paid $4.2M of that.
Pay$100 in the stock at the end of FY20 → $120
Pay of each named executive
Gregory A. Demopulos, M.D.President, Chief Executive Officer and Chairman of the Board
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) | ||||||
| FY2021 (Dec) |
5 years
Peter B. Cancelmo, J.D.Vice President, General Counsel and Secretary
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) | ||||||
| FY2021 (Dec) |
5 years
David J. BorgesVice President, Finance, Chief Accounting Officer and Treasurer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) |
2 years
CEO pay against the pay peers
In FY2025 (Dec), the median CEO pay of the 7 peers with pay on file was $3.4M. CEO pay of Omeros for that year is not on file.
- 1Arcus Biosciences
- 2Agios Pharmaceuticals
- 3Vanda Pharmaceuticals
- 4Aclaris Therapeutics
- 5Enanta Pharmaceuticals
- 6Ironwood Pharmaceuticals
- 7Collegium Pharmaceutical
- 8OmerosThis companyNot disclosed
- 9Coherus BioSciences, Inc.Not disclosed
- 10Esperion Therapeutics, Inc.Not disclosed
- 11Karyopharm Therapeutics Inc.Not disclosed
- 12Mersana Therapeutics, Inc.Not disclosed
- 13Pacira BioSciencesNot disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.